Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose, Cipla Australia Pty Ltd, CON-662
Product name
Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose
Sponsor name
Cipla Australia Pty Ltd
Consent start
Consent no.
CON-662
Standard
Therapeutic Goods Order No. 91 '“ Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not conform with the requirements of TGO 91 but are supplied
with labels that have been approved by the TGA.
Therapeutic product type
Prescription medicines